Oral cefixime is no longer first-line for gonorrhea

October 2012

Oral cefixime is no longer first-line for gonorrhea...due to increasing resistance.

This means no more preferred regimens with just ORAL drugs.

Recommend ceftriaxone 250 mg IM PLUS azithromycin 1 g for most patients with gonorrhea. Using two drugs will hopefully slow resistance.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Infectious Diseases This will be the worst year yet for West Nile virus
Overactive Bladder Myrbetriq (meer-BEH-trick, mirabegron) for overactive bladder
Diabetes you'll hear MORE controversy about using pioglitazone (Actos) for type 2 diabetes
Hypertension debate about when to start drugs in patients with MILD hypertension
Vaccines New virus strains in the 2012-2013 influenza vaccine
Antipsychotics whether it makes sense to use more than one antipsychotic for schizophrenia
STIs Oral cefixime is no longer first-line for gonorrhea
Depression more emphasis on treating depression in cardiac patients
Respiratory & Allergy The new OTC bronchodilator Asthmanefrin (racepinephrine) will be promoted as an alternative to Primatene Mist (epinephrine)
Respiratory & Allergy whether inhaled corticosteroids inhibit growth in kids or increase fracture risk in seniors
Substance Use Disorder Patients are abusing Suboxone (buprenorphine/naloxone) tabs
Education and Training how and why you need to get an e-Profile ID to meet the new CE reporting requirements